By the analysis of network pharmacology, six compounds in SPN were predicted to be the anti-anemia ones corresponding to the three targets involved in the JAK-STAT signal pathway, which were ginsenosides Rh4, Rk3, Rb2, 20(R)-Rg3, Rd, and notoginsenoside C (Figure 9). The gene discussed is RBL2; the disease is anemia.